Recruiting Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors NCT07218913 Conditions Ear Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
Active, Not Recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic NCT02721732 Conditions Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +59 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
